# ISO 42001: AI Management System (AIMS) Policy

**Version:** 1.0  
**Effective Date:** March 26, 2026  
**Owner:** CEO / Chief Medical Information Officer  
**Scope:** Pixelence MRI System (cGAN-based MRI Enhancement)

## 1. Introduction and Purpose
Pixelence is committed to the development and deployment of Artificial Intelligence (AI) that is safe, effective, and ethically responsible. This policy establishes the framework for our AI Management System (AIMS) in accordance with the **ISO 42001** international standard.

## 2. Ethical AI Guiding Principles
Our AI systems shall adhere to the following core principles:
- **Safety and Efficacy:** AI-enhanced medical images must not introduce clinically misleading artifacts.
- **Transparency:** Clearly distinguish between raw scans and AI-generated enhancements.
- **Non-Discrimination:** Training data must be diversely sourced to prevent bias against any demographic.
- **Human Oversight:** All AI-based reports must be verified and approved by a qualified radiologist before clinical use.

## 3. Data Governance for AI (Control B.7)
Data used for training and inference must be managed with high integrity:
- **Anonymization:** All medical scans must be de-identified according to HIPAA/GDPR standards before entering the AI pipeline.
- **Traceability:** Maintain a record of the origin, version, and characteristics of training datasets (e.g., the 250,000 scans referenced in BrainSR v1.0.3).
- **Quality Assurance:** Validate data integrity (e.g., DICOM format checks) before processing.

## 4. AI Risk Management (Control B.8)
A formal AI Risk Assessment (AIRA) shall be conducted annually to identify:
- **Clinical Risks:** Potential for misdiagnosis due to model "hallucinations" or smoothing.
- **Technical Risks:** Model drift, dependency failures (e.g., VGG19/InceptionV3 updates), and adversarial attacks.
- **Mitigation:** Fallback mechanisms (viewing RAW images) and rigorous validation against ground-truth contrast scans.

## 5. Model Lifecycle and Versioning (Control B.5)
- **Versioning:** Every model update must be versioned (e.g., v1.0.3) and have documented evaluation metrics (PSNR, SSIM).
- **Storage:** Models must be stored securely with encryption-at-rest (`secret.key` managed by secure vault).
- **Deployment:** Only models that have passed UAT (User Acceptance Testing) and clinical validation are promoted to production.

## 6. Performance Monitoring (Control B.9)
- Real-time monitoring of inference latency and system resource usage.
- Periodic auditing of AI outputs against expert radiologist findings to assess "Model Reliability."
- Incident reporting system for any cases where AI enhancement negatively impacts diagnostic clarity.

## 7. Regulatory and Legal Compliance
Pixelence acknowledges that the AI system is currently a **research tool**. We commit to pursuing:
- CE Marking / FDA 510(k) as applicable before clinical commercialization.
- Alignment with local and international AI safety regulations (e.g., EU AI Act).

## 8. Continuous Improvement
The AIMS policy and its associated procedures will be reviewed at least annually to adapt to technological advancements and evolving regulatory landscapes.

---

**Approval:**  
*__________________________*  
*Director of AI Research*  
*__________________________*  
*Information Security Officer*
